{"Symbol": "BRLI", "AssetType": "Common Stock", "Name": "Bio-Reference Laboratories Inc", "Description": "Brilliant Acquisition Corporation operates as a blank check company. It focuses on acquiring; engaging in share exchange and share reconstruction; purchasing the assets; entering into contractual arrangements; and engaging in similar business combination with one or more businesses. The company was founded in 2019 and is based in Shanghai, China.", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "Financial Services", "Industry": "Shell Companies", "Address": "481 Edward H. Ross Drive\n07407,Elmwood Park,USA\n", "FullTimeEmployees": "0", "FiscalYearEnd": "October", "LatestQuarter": "None", "MarketCapitalization": "52332000", "EBITDA": "None", "PERatio": "-99999.99", "PEGRatio": "None", "BookValue": "None", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-99999.99", "RevenuePerShareTTM": "0", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "0", "ReturnOnEquityTTM": "0", "RevenueTTM": "0", "GrossProfitTTM": "0", "DilutedEPSTTM": "0", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "None", "TrailingPE": "0", "ForwardPE": "0", "PriceToSalesRatioTTM": "0", "PriceToBookRatio": "0", "EVToRevenue": "0", "EVToEBITDA": "0", "Beta": "None", "52WeekHigh": "None", "52WeekLow": "None", "50DayMovingAverage": "0", "200DayMovingAverage": "0", "SharesOutstanding": "0", "SharesFloat": "0", "SharesShort": "0", "SharesShortPriorMonth": "0", "ShortRatio": "0", "ShortPercentOutstanding": "0", "ShortPercentFloat": "0", "PercentInsiders": "0", "PercentInstitutions": "0", "ForwardAnnualDividendRate": "0", "ForwardAnnualDividendYield": "0", "PayoutRatio": "0", "DividendDate": "None", "ExDividendDate": "None", "LastSplitFactor": "None", "LastSplitDate": "None"}